Jeffrey A. Stafford
Founder at 858 Therapeutics, Inc.
Jeffrey A. Stafford active positions
Companies | Position | Start | End |
---|---|---|---|
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 2018-12-31 | - |
Chief Executive Officer | 2018-12-31 | - | |
Founder | 2018-12-31 | - | |
President | 2018-12-31 | - |
Career history of Jeffrey A. Stafford
Former positions of Jeffrey A. Stafford
Companies | Position | Start | End |
---|---|---|---|
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Chief Executive Officer | - | 2019-04-30 |
Founder | - | 2019-04-30 | |
Takeda San Diego, Inc.
Takeda San Diego, Inc. Medical DistributorsDistribution Services Takeda San Diego, Inc. discovers drugs for cancer treatment. It integrates protein crystallography and drug discovery technologies to generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. The company was founded in 1781 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2001-12-31 | 2008-12-31 |
Quanticel Pharmaceuticals, Inc.
Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | - | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - | - |
Training of Jeffrey A. Stafford
University of California, Los Angeles | Undergraduate Degree |
Cornell University | Doctorate Degree |
Statistics
International
United States | 7 |
Canada | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Takeda San Diego, Inc.
Takeda San Diego, Inc. Medical DistributorsDistribution Services Takeda San Diego, Inc. discovers drugs for cancer treatment. It integrates protein crystallography and drug discovery technologies to generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. The company was founded in 1781 and is headquartered in San Diego, CA. | Distribution Services |
Quanticel Pharmaceuticals, Inc.
Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Health Technology |
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Commercial Services |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey A. Stafford
- Experience